( October 7, 2026, 3:48 PM EDT) -- NEWARK, N.J. — A federal judge granted AstraZeneca’s bid to restrict a defense expert’s testimony in litigation over patents covering its cancer drug Lynparza pending in a New Jersey federal court, ruling that the expert is qualified to testify about medicinal chemistry but not genetics, cancer cell biology, clinical trial interpretation or cancer treatment....